This document provides a summary of activities at Akesta General Hospital from the previous six months. It includes a list of acronyms, previous action points from catchment area meetings, major transition activities, HIV prevention activities, first 95 performance on HIV testing and ART initiation, second 95 performance on ART optimization and retention, TB/HIV collaboration, pediatric psychosocial support, cervical cancer screening, mental health integration, third 95 performance on viral load testing, and rapid test kit supply status. The document reports on performance indicators and identifies gaps to address in order to improve HIV care and treatment services.
2016 indicator reference guide at-risk infants tested for hiv#GOMOJO, INC.
This document defines the indicator "Percentage of infants born to HIV-positive women who had a virologic HIV test done within 12 months of birth". It provides details on the numerator, denominator, and disaggregation categories for this indicator, which measures how many exposed infants receive early testing to determine their HIV status. Early diagnosis is critical to ensure untreated infants receive necessary treatment. The document also describes how to calculate and interpret this indicator, and what types of PEPFAR support can be counted.
2016 indicator reference guide Prevention Services#GOMOJO, INC.
1) This indicator measures the percentage of pregnant women who know their HIV status, including those tested and received results, to monitor progress toward eliminating mother-to-child transmission of HIV.
2) The data will help identify progress, determine assistance needed, and monitor implementation of prevention of mother-to-child transmission programs.
3) Both those directly served and receiving technical assistance should report results to headquarters.
This report provides an analysis of HIV and STI surveillance data from Papua New Guinea in 2012. Key findings include:
- A total of 200,711 HIV tests were conducted, of which 4,723 (2.35%) were positive. Testing was higher among females.
- Nine provinces had HIV positivity rates above 1% among antenatal clients, with the highest in Enga (6.12%), Western Highlands (4.28%), and National Capital District (4.14%).
- 2,857 new HIV-positive cases were reported nationally. Most cases originated from and resided in provinces in the Highlands and Southern regions, particularly Enga, Southern Highlands, and Eastern
This document summarizes a national review meeting on TB Free Nepal Initiative held in Dullu, Dailekh province from Shrawan to Baisakh 2079. It provides details on coverage of services, program management indicators, screening and diagnosis statistics, contact tracing, budget allocation and expenditures, challenges and the way forward. Key highlights include 17 health facilities providing DOTS services, 300 people screened for TB with 90 presumptive cases identified, and 19 index cases with 19 contacts identified and screened. The annual budget was 30 million rupees with 24 million received from the center and 6 million from the local level.
Conclave indrajit - evidence for policy & impact - 22 apr 2016 v2.1Indrajit Chaudhuri
1) CARE India worked in Bihar through its Bihar Technical Support Program (BTSP) to reduce maternal and child health indicators like MMR, NMR, and malnutrition. It tested and implemented innovative solutions in select districts from 2010-2013.
2) Four key solutions showed successful results - sub-center meetings, quality improvement and nurse mentoring in facilities, team-based goals and incentives for frontline workers, and a comprehensive mHealth solution.
3) These solutions were adopted and scaled up by the Bihar government based on the evidence from their measurement and learning efforts. For example, sub-center meetings were scaled up statewide and the mobile nurse mentoring approach was replicated in many other states. This
The document describes several projects aimed at increasing chlamydia screening rates. It discusses the Center for Health Training's development of a toolkit for STD care for American Indians/Alaska Natives. It also summarizes projects focused on community outreach and education for chlamydia screening in rural and underserved areas.
This document contains indicators and definitions for monitoring antiretroviral therapy (ART) programs in Kenya. It provides details on 14 indicators for tracking things like the entry points of patients enrolled in comprehensive HIV care, the percentage of positive patients referred from voluntary counseling and testing who register for care, and numbers of patients eligible for and starting ART. The goal is to monitor patient flows and identify areas where counseling, referral, and initiation of treatment can be improved to ensure all HIV-positive patients receive appropriate care and treatment.
2016 indicator reference guide at-risk infants tested for hiv#GOMOJO, INC.
This document defines the indicator "Percentage of infants born to HIV-positive women who had a virologic HIV test done within 12 months of birth". It provides details on the numerator, denominator, and disaggregation categories for this indicator, which measures how many exposed infants receive early testing to determine their HIV status. Early diagnosis is critical to ensure untreated infants receive necessary treatment. The document also describes how to calculate and interpret this indicator, and what types of PEPFAR support can be counted.
2016 indicator reference guide Prevention Services#GOMOJO, INC.
1) This indicator measures the percentage of pregnant women who know their HIV status, including those tested and received results, to monitor progress toward eliminating mother-to-child transmission of HIV.
2) The data will help identify progress, determine assistance needed, and monitor implementation of prevention of mother-to-child transmission programs.
3) Both those directly served and receiving technical assistance should report results to headquarters.
This report provides an analysis of HIV and STI surveillance data from Papua New Guinea in 2012. Key findings include:
- A total of 200,711 HIV tests were conducted, of which 4,723 (2.35%) were positive. Testing was higher among females.
- Nine provinces had HIV positivity rates above 1% among antenatal clients, with the highest in Enga (6.12%), Western Highlands (4.28%), and National Capital District (4.14%).
- 2,857 new HIV-positive cases were reported nationally. Most cases originated from and resided in provinces in the Highlands and Southern regions, particularly Enga, Southern Highlands, and Eastern
This document summarizes a national review meeting on TB Free Nepal Initiative held in Dullu, Dailekh province from Shrawan to Baisakh 2079. It provides details on coverage of services, program management indicators, screening and diagnosis statistics, contact tracing, budget allocation and expenditures, challenges and the way forward. Key highlights include 17 health facilities providing DOTS services, 300 people screened for TB with 90 presumptive cases identified, and 19 index cases with 19 contacts identified and screened. The annual budget was 30 million rupees with 24 million received from the center and 6 million from the local level.
Conclave indrajit - evidence for policy & impact - 22 apr 2016 v2.1Indrajit Chaudhuri
1) CARE India worked in Bihar through its Bihar Technical Support Program (BTSP) to reduce maternal and child health indicators like MMR, NMR, and malnutrition. It tested and implemented innovative solutions in select districts from 2010-2013.
2) Four key solutions showed successful results - sub-center meetings, quality improvement and nurse mentoring in facilities, team-based goals and incentives for frontline workers, and a comprehensive mHealth solution.
3) These solutions were adopted and scaled up by the Bihar government based on the evidence from their measurement and learning efforts. For example, sub-center meetings were scaled up statewide and the mobile nurse mentoring approach was replicated in many other states. This
The document describes several projects aimed at increasing chlamydia screening rates. It discusses the Center for Health Training's development of a toolkit for STD care for American Indians/Alaska Natives. It also summarizes projects focused on community outreach and education for chlamydia screening in rural and underserved areas.
This document contains indicators and definitions for monitoring antiretroviral therapy (ART) programs in Kenya. It provides details on 14 indicators for tracking things like the entry points of patients enrolled in comprehensive HIV care, the percentage of positive patients referred from voluntary counseling and testing who register for care, and numbers of patients eligible for and starting ART. The goal is to monitor patient flows and identify areas where counseling, referral, and initiation of treatment can be improved to ensure all HIV-positive patients receive appropriate care and treatment.
The document provides information on a M&E training for the Global Fund's Round 9. It discusses key topics including:
- What the Global Fund is and its principles of international health financing and performance-based funding.
- The importance of M&E in grant management and the basic elements of an M&E system including monitoring, evaluation, indicators, and the M&E process.
- Details of Myanmar's Performance Framework for its HIV grant, including objectives, indicators, targets, and periods covered.
- Additional M&E topics like the M&E plan, data collection and management, evaluation, strategic information, capacity building, and coordination.
The document is Kansas' comprehensive HIV prevention program plan for 2012-2016. It provides contact information for the program and describes the required and recommended program components being implemented, including HIV testing, prevention with positives, condom distribution, and evidence-based interventions. It identifies the cities bearing the largest burden of HIV in Kansas and the funding allocated to each. Goals, objectives, and annual targets are provided for expanding HIV testing, linking those infected to care, and enrolling high-risk negatives in prevention programs.
HIV Index Testing: The USAID DISCOVER-Health Project Experience in Zambia JSI
The USAID DISCOVER-Health Project has been implementing HIV index testing and partner notification services since November 2017 in 138 sites across 11 hubs in order to more efficiently test for HIV and contribute to epidemic control. Index testing has yielded a high positivity rate of 23% and has tested more males than other modalities, showing its potential to reach male partners. The project aims to increase the contribution of index testing to 40% of all new HIV cases identified through ongoing capacity building, mentorship, and allowing the model to evolve dynamically. Key lessons include the need for adequate training and support for health care workers implementing index testing.
Cascade of HIV Care, PMTCT and TB/HIV Services in CambodiaMatt Avery
The document summarizes Cambodia's cascade of HIV care, prevention of mother-to-child transmission (PMTCT), and tuberculosis/HIV services in 2012. It shows the number of people tested and retained at each step of testing and treatment. For example, over 40,000 new TB cases were registered but only 1,657 HIV+ TB cases received antiretroviral treatment. For PMTCT, 1,464 pregnant women were estimated to have HIV but only 249 infants received early infant diagnosis. The document proposes a framework for monitoring cascade indicators and developing national and sub-national indicators based on available data in Cambodia.
Make them count using the best data for maximum impactnewborn1
This document discusses indicators for measuring newborn health and mortality. It outlines progress made by various groups in establishing standardized indicators, including:
1. The Newborn Indicator Technical Working Group is working to establish core indicators for postnatal care, newborn behaviors, and newborn services in facilities.
2. The Countdown to 2015 initiative tracks coverage of interventions to reduce maternal and child mortality in 68 countries.
3. Core indicators are proposed for measuring kangaroo mother care in facilities, including the percentage of low birthweight babies receiving kangaroo mother care.
This report summarizes a supervision visit by a TB/HIV focal person to Ceegbah Clinic in Grand Bassa County, Liberia. Key findings include:
- During the first two quarters of 2017, the clinic reported 1 smear-positive TB case and 2 extra-pulmonary TB cases. Mentoring was provided on improving TB recording and reporting.
- For HIV services from January to June 2017, 5 pregnant women tested HIV-positive and were started on treatment. Challenges included stockouts of test kits and medicines.
- HIV testing among other patients was low. Two patients who tested positive refused treatment. Mentoring was provided on counseling those refusing treatment.
- Stock
The document discusses the FOCUS program's efforts to implement universal HIV and hepatitis C testing in the UCSD emergency departments. Over 15 months, 13,817 patients were tested for HIV, identifying 47 positives and linking 30 of 33 new diagnoses to care. A one-month HCV pilot screened 970 patients, identifying 90 antibody positives and linking 13 of 29 RNA-positive patients to care. The FOCUS team aims to expand HIV and HCV testing, screening 13,000 patients annually for each virus and linking over 90% of new diagnoses to care. Challenges include complex patient disclosures, false positive HIV tests, and ensuring patients understand results and are successfully linked to ongoing medical care.
2015 indicator reference guide viral load suppression at 12 months#GOMOJO, INC.
This document provides guidance on the indicator "Percentage of ART patients with a viral load result documented in the medical record within the past 12 months". It aims to monitor the proportion of patients on antiretroviral therapy (ART) who receive routine viral load testing to determine treatment effectiveness. The numerator is the number of ART patients with a documented viral load result in their medical record from the past 12 months. The denominator is the number of ART patients whose medical records were reviewed who have been on treatment for at least 6 months. Achieving high rates of routine viral load testing is important for sustaining treatment outcomes and reducing transmission at scale.
15.45 p.m. 16.30 p.m. learning from audits and incidents - pbPHEScreening
1) An audit of AAA screening program operational meetings found variable compliance with standards, with only half meeting monthly as required. Key learning included developing terms of reference and improving meeting attendance and record-keeping.
2) An analysis of AAA screening incidents in London from 2014-2016 identified 17 screening safety incidents and 1 serious incident reported, with varying timescales for investigation. Themes included issues with ultrasound machines, delayed letter printing, and unregistered patients.
3) Lessons from national AAA screening incidents from April-October 2016 involved 21 reported incidents affecting 466 people. Themes included hospital referral delays and strengthened medical history checks. Improved tracking processes and administrative support were recommended.
This document outlines indicators to measure progress towards the strategic objective of improving prevention of mother-to-child HIV transmission in Mukuru, Kenya. It describes three indicators related to: 1) increasing the percentage of HIV positive mothers abstaining from breastfeeding over 3 years; 2) doubling the percentage of pregnant women tested for HIV over 3 years; and 3) doubling the percentage of HIV positive pregnant women receiving AZT treatment over 3 years. Data will be collected through surveys, interviews and clinic records, analyzed, reported annually and presented to stakeholders.
2016 indicator reference guide viral load suppression at 12 months#GOMOJO, INC.
1) This indicator measures the percentage of ART patients with a viral load result documented within the past 12 months. Viral load testing is important for monitoring treatment effectiveness and preventing drug resistance.
2) The numerator is the number of ART patients (adults and children) with a viral load result documented in their medical record within the past 12 months. The denominator is the number of ART patients reviewed whose medical records were examined.
3) Achieving high rates of viral load testing is critical for monitoring treatment outcomes and scaling up HIV treatment programs. Support for viral load testing includes procurement of reagents, transportation of samples, and clinical mentoring at ART sites.
2016 indicator reference guide retained on art at 12 months#GOMOJO, INC.
This indicator measures the proportion of individuals who have retained on antiretroviral therapy (ART) 12 months after initiation. The numerator is the number of adults and children alive and on ART at 12 months. The denominator is the total number who initiated ART in the 12 months prior. Disaggregation is required by age, sex, pregnancy status, and key populations. Retention is critical for reducing morbidity and mortality, and is a proxy for program quality. Sites should review retention regularly to improve follow-up and retention.
The document discusses counselling and testing in the context of preventing mother-to-child transmission (PMTCT) of HIV. It covers the benefits of testing, approaches to testing such as opt-in and opt-out, algorithms for using multiple rapid HIV tests, diagnosing HIV in infants exposed to HIV, and the timing of testing including pre-pregnancy, antenatal, intrapartum, and postpartum. General information is also provided on confidentiality, the types of counselling given before and after testing, and working with couples to involve male partners.
South EIP Programme Support and Assurance 2018-19Sarah Amani
A brief summary of the focus of the work of the South of England Early Intervention in Psychosis (EIP) Programme in 2018-19 as we work across systems, organisations and teams to drive better quality and outcomes for people with early psychosis and their families.
Testing for Acute HIV and Early Initiation of ARTHopkinsCFAR
This document summarizes evidence from several studies on testing for acute HIV infection and initiating antiretroviral therapy (ART) on the same day as diagnosis. It discusses the optimal window for initiating ART after infection to restore immune function based on a study showing greater probability of achieving CD4 counts over 900 if starting ART within 4 months of infection. It also summarizes results from randomized controlled trials and observational studies demonstrating that rapid/same-day ART initiation improves linkage to care, ART initiation rates, and viral suppression compared to standard of care with initiation delayed by weeks or months.
Presentation: Results of National Adherence PHEicapclinical
1. Rwanda's national HIV prevention, care, and treatment program has seen significant progress between 2004-2008, with HIV testing rates, ART coverage, and health facility participation all increasing substantially.
2. While barriers to PMTCT participation like fear of testing positive and partner disclosure remain challenges, programs have addressed issues like breastfeeding support and improving ANC attendance.
3. Clinical outcomes of ART have been positive, with high retention and adherence rates and significant CD4 count increases showing the effectiveness of treatment. Continued decentralization and integration of services is planned to further improve coverage.
SMS for Life_MINSANTE Presentation_06032015_IOmulepuandrew wyborn
The document summarizes the national implementation of SMS for Life in Cameroon to improve data collection and management across various health programs. SMS for Life uses mobile phones and the Mango platform to collect commodity stock data, surveillance data, and other health information in real-time from health facilities. This data is then aggregated and shared with the Ministry of Health and partner organizations to provide greater visibility and informed decision making. The program aims to reduce stockouts, improve data quality and coordination across programs, and support the health system in Cameroon.
The document summarizes a study examining hepatitis B virus (HBV) and hepatitis C virus (HCV) testing and services offered by substance abuse treatment programs in the United States. The study surveyed 269 program administrators and found that while most programs provided some HCV testing, comprehensive HBV and HCV testing and vaccination services were lacking. Programs with clear HCV guidelines and methadone programs offered more HCV services compared to those without guidelines or non-methadone programs. The study concluded that public health interventions are needed to improve viral hepatitis services for substance abusers.
This document outlines the monitoring and evaluation processes for community-based organizations providing HIV/AIDS services. It discusses:
Daily data entry into mobile applications with weekly verification. Monthly reports are compiled, validated at local levels, and sent to higher levels. Quarterly reports are also written. It describes the roles and responsibilities of various staff at different levels for data collection, reporting, and oversight. Key indicators are also listed that must be reported by the community-based organizations. Upcoming capacity building activities are noted.
This document discusses the history and development of paramedic practitioners and community paramedicine in the UK. It traces the evolution of paramedic training from 2005 to becoming degree-level in 2019. It also outlines key reports and pilots that expanded the paramedic role to provide more care in the community. The community paramedic model aims to improve access, reduce conveyance rates, and shift more treatment out of hospitals. Initial indicators from the Thanet pilot show improved response times and higher staff satisfaction with the new model.
The document provides information on a M&E training for the Global Fund's Round 9. It discusses key topics including:
- What the Global Fund is and its principles of international health financing and performance-based funding.
- The importance of M&E in grant management and the basic elements of an M&E system including monitoring, evaluation, indicators, and the M&E process.
- Details of Myanmar's Performance Framework for its HIV grant, including objectives, indicators, targets, and periods covered.
- Additional M&E topics like the M&E plan, data collection and management, evaluation, strategic information, capacity building, and coordination.
The document is Kansas' comprehensive HIV prevention program plan for 2012-2016. It provides contact information for the program and describes the required and recommended program components being implemented, including HIV testing, prevention with positives, condom distribution, and evidence-based interventions. It identifies the cities bearing the largest burden of HIV in Kansas and the funding allocated to each. Goals, objectives, and annual targets are provided for expanding HIV testing, linking those infected to care, and enrolling high-risk negatives in prevention programs.
HIV Index Testing: The USAID DISCOVER-Health Project Experience in Zambia JSI
The USAID DISCOVER-Health Project has been implementing HIV index testing and partner notification services since November 2017 in 138 sites across 11 hubs in order to more efficiently test for HIV and contribute to epidemic control. Index testing has yielded a high positivity rate of 23% and has tested more males than other modalities, showing its potential to reach male partners. The project aims to increase the contribution of index testing to 40% of all new HIV cases identified through ongoing capacity building, mentorship, and allowing the model to evolve dynamically. Key lessons include the need for adequate training and support for health care workers implementing index testing.
Cascade of HIV Care, PMTCT and TB/HIV Services in CambodiaMatt Avery
The document summarizes Cambodia's cascade of HIV care, prevention of mother-to-child transmission (PMTCT), and tuberculosis/HIV services in 2012. It shows the number of people tested and retained at each step of testing and treatment. For example, over 40,000 new TB cases were registered but only 1,657 HIV+ TB cases received antiretroviral treatment. For PMTCT, 1,464 pregnant women were estimated to have HIV but only 249 infants received early infant diagnosis. The document proposes a framework for monitoring cascade indicators and developing national and sub-national indicators based on available data in Cambodia.
Make them count using the best data for maximum impactnewborn1
This document discusses indicators for measuring newborn health and mortality. It outlines progress made by various groups in establishing standardized indicators, including:
1. The Newborn Indicator Technical Working Group is working to establish core indicators for postnatal care, newborn behaviors, and newborn services in facilities.
2. The Countdown to 2015 initiative tracks coverage of interventions to reduce maternal and child mortality in 68 countries.
3. Core indicators are proposed for measuring kangaroo mother care in facilities, including the percentage of low birthweight babies receiving kangaroo mother care.
This report summarizes a supervision visit by a TB/HIV focal person to Ceegbah Clinic in Grand Bassa County, Liberia. Key findings include:
- During the first two quarters of 2017, the clinic reported 1 smear-positive TB case and 2 extra-pulmonary TB cases. Mentoring was provided on improving TB recording and reporting.
- For HIV services from January to June 2017, 5 pregnant women tested HIV-positive and were started on treatment. Challenges included stockouts of test kits and medicines.
- HIV testing among other patients was low. Two patients who tested positive refused treatment. Mentoring was provided on counseling those refusing treatment.
- Stock
The document discusses the FOCUS program's efforts to implement universal HIV and hepatitis C testing in the UCSD emergency departments. Over 15 months, 13,817 patients were tested for HIV, identifying 47 positives and linking 30 of 33 new diagnoses to care. A one-month HCV pilot screened 970 patients, identifying 90 antibody positives and linking 13 of 29 RNA-positive patients to care. The FOCUS team aims to expand HIV and HCV testing, screening 13,000 patients annually for each virus and linking over 90% of new diagnoses to care. Challenges include complex patient disclosures, false positive HIV tests, and ensuring patients understand results and are successfully linked to ongoing medical care.
2015 indicator reference guide viral load suppression at 12 months#GOMOJO, INC.
This document provides guidance on the indicator "Percentage of ART patients with a viral load result documented in the medical record within the past 12 months". It aims to monitor the proportion of patients on antiretroviral therapy (ART) who receive routine viral load testing to determine treatment effectiveness. The numerator is the number of ART patients with a documented viral load result in their medical record from the past 12 months. The denominator is the number of ART patients whose medical records were reviewed who have been on treatment for at least 6 months. Achieving high rates of routine viral load testing is important for sustaining treatment outcomes and reducing transmission at scale.
15.45 p.m. 16.30 p.m. learning from audits and incidents - pbPHEScreening
1) An audit of AAA screening program operational meetings found variable compliance with standards, with only half meeting monthly as required. Key learning included developing terms of reference and improving meeting attendance and record-keeping.
2) An analysis of AAA screening incidents in London from 2014-2016 identified 17 screening safety incidents and 1 serious incident reported, with varying timescales for investigation. Themes included issues with ultrasound machines, delayed letter printing, and unregistered patients.
3) Lessons from national AAA screening incidents from April-October 2016 involved 21 reported incidents affecting 466 people. Themes included hospital referral delays and strengthened medical history checks. Improved tracking processes and administrative support were recommended.
This document outlines indicators to measure progress towards the strategic objective of improving prevention of mother-to-child HIV transmission in Mukuru, Kenya. It describes three indicators related to: 1) increasing the percentage of HIV positive mothers abstaining from breastfeeding over 3 years; 2) doubling the percentage of pregnant women tested for HIV over 3 years; and 3) doubling the percentage of HIV positive pregnant women receiving AZT treatment over 3 years. Data will be collected through surveys, interviews and clinic records, analyzed, reported annually and presented to stakeholders.
2016 indicator reference guide viral load suppression at 12 months#GOMOJO, INC.
1) This indicator measures the percentage of ART patients with a viral load result documented within the past 12 months. Viral load testing is important for monitoring treatment effectiveness and preventing drug resistance.
2) The numerator is the number of ART patients (adults and children) with a viral load result documented in their medical record within the past 12 months. The denominator is the number of ART patients reviewed whose medical records were examined.
3) Achieving high rates of viral load testing is critical for monitoring treatment outcomes and scaling up HIV treatment programs. Support for viral load testing includes procurement of reagents, transportation of samples, and clinical mentoring at ART sites.
2016 indicator reference guide retained on art at 12 months#GOMOJO, INC.
This indicator measures the proportion of individuals who have retained on antiretroviral therapy (ART) 12 months after initiation. The numerator is the number of adults and children alive and on ART at 12 months. The denominator is the total number who initiated ART in the 12 months prior. Disaggregation is required by age, sex, pregnancy status, and key populations. Retention is critical for reducing morbidity and mortality, and is a proxy for program quality. Sites should review retention regularly to improve follow-up and retention.
The document discusses counselling and testing in the context of preventing mother-to-child transmission (PMTCT) of HIV. It covers the benefits of testing, approaches to testing such as opt-in and opt-out, algorithms for using multiple rapid HIV tests, diagnosing HIV in infants exposed to HIV, and the timing of testing including pre-pregnancy, antenatal, intrapartum, and postpartum. General information is also provided on confidentiality, the types of counselling given before and after testing, and working with couples to involve male partners.
South EIP Programme Support and Assurance 2018-19Sarah Amani
A brief summary of the focus of the work of the South of England Early Intervention in Psychosis (EIP) Programme in 2018-19 as we work across systems, organisations and teams to drive better quality and outcomes for people with early psychosis and their families.
Testing for Acute HIV and Early Initiation of ARTHopkinsCFAR
This document summarizes evidence from several studies on testing for acute HIV infection and initiating antiretroviral therapy (ART) on the same day as diagnosis. It discusses the optimal window for initiating ART after infection to restore immune function based on a study showing greater probability of achieving CD4 counts over 900 if starting ART within 4 months of infection. It also summarizes results from randomized controlled trials and observational studies demonstrating that rapid/same-day ART initiation improves linkage to care, ART initiation rates, and viral suppression compared to standard of care with initiation delayed by weeks or months.
Presentation: Results of National Adherence PHEicapclinical
1. Rwanda's national HIV prevention, care, and treatment program has seen significant progress between 2004-2008, with HIV testing rates, ART coverage, and health facility participation all increasing substantially.
2. While barriers to PMTCT participation like fear of testing positive and partner disclosure remain challenges, programs have addressed issues like breastfeeding support and improving ANC attendance.
3. Clinical outcomes of ART have been positive, with high retention and adherence rates and significant CD4 count increases showing the effectiveness of treatment. Continued decentralization and integration of services is planned to further improve coverage.
SMS for Life_MINSANTE Presentation_06032015_IOmulepuandrew wyborn
The document summarizes the national implementation of SMS for Life in Cameroon to improve data collection and management across various health programs. SMS for Life uses mobile phones and the Mango platform to collect commodity stock data, surveillance data, and other health information in real-time from health facilities. This data is then aggregated and shared with the Ministry of Health and partner organizations to provide greater visibility and informed decision making. The program aims to reduce stockouts, improve data quality and coordination across programs, and support the health system in Cameroon.
The document summarizes a study examining hepatitis B virus (HBV) and hepatitis C virus (HCV) testing and services offered by substance abuse treatment programs in the United States. The study surveyed 269 program administrators and found that while most programs provided some HCV testing, comprehensive HBV and HCV testing and vaccination services were lacking. Programs with clear HCV guidelines and methadone programs offered more HCV services compared to those without guidelines or non-methadone programs. The study concluded that public health interventions are needed to improve viral hepatitis services for substance abusers.
This document outlines the monitoring and evaluation processes for community-based organizations providing HIV/AIDS services. It discusses:
Daily data entry into mobile applications with weekly verification. Monthly reports are compiled, validated at local levels, and sent to higher levels. Quarterly reports are also written. It describes the roles and responsibilities of various staff at different levels for data collection, reporting, and oversight. Key indicators are also listed that must be reported by the community-based organizations. Upcoming capacity building activities are noted.
This document discusses the history and development of paramedic practitioners and community paramedicine in the UK. It traces the evolution of paramedic training from 2005 to becoming degree-level in 2019. It also outlines key reports and pilots that expanded the paramedic role to provide more care in the community. The community paramedic model aims to improve access, reduce conveyance rates, and shift more treatment out of hospitals. Initial indicators from the Thanet pilot show improved response times and higher staff satisfaction with the new model.
Similar to Catchment area meeting HIV report.pptx (20)
Michigan HealthTech Market Map 2024. Includes 7 categories: Policy Makers, Academic Innovation Centers, Digital Health Providers, Healthcare Providers, Payers / Insurance, Device Companies, Life Science Companies, Innovation Accelerators. Developed by the Michigan-Israel Business Accelerator
About this webinar: This talk will introduce what cancer rehabilitation is, where it fits into the cancer trajectory, and who can benefit from it. In addition, the current landscape of cancer rehabilitation in Canada will be discussed and the need for advocacy to increase access to this essential component of cancer care.
PET CT beginners Guide covers some of the underrepresented topics in PET CTMiadAlsulami
This lecture briefly covers some of the underrepresented topics in Molecular imaging with cases , such as:
- Primary pleural tumors and pleural metastases.
- Distinguishing between MPM and Talc Pleurodesis.
- Urological tumors.
- The role of FDG PET in NET.
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...Ear Solutions (ESPL)
Binaural hearing using two hearing aids instead of one offers numerous advantages, including improved sound localization, enhanced sound quality, better speech understanding in noise, reduced listening effort, and greater overall satisfaction. By leveraging the brain’s natural ability to process sound from both ears, binaural hearing aids provide a more balanced, clear, and comfortable hearing experience. If you or a loved one is considering hearing aids, consult with a hearing care professional at Ear Solutions hearing aid clinic in Mumbai to explore the benefits of binaural hearing and determine the best solution for your hearing needs. Embracing binaural hearing can lead to a richer, more engaging auditory experience and significantly improve your quality of life.
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdfDr Rachana Gujar
Introduction: Substance use education is crucial due to its prevalence and societal impact.
Alcohol Use: Immediate and long-term risks include impaired judgment, health issues, and social consequences.
Tobacco Use: Immediate effects include increased heart rate, while long-term risks encompass cancer and heart disease.
Drug Use: Risks vary depending on the drug type, including health and psychological implications.
Prevention Strategies: Education, healthy coping mechanisms, community support, and policies are vital in preventing substance use.
Harm Reduction Strategies: Safe use practices, medication-assisted treatment, and naloxone availability aim to reduce harm.
Seeking Help for Addiction: Recognizing signs, available treatments, support systems, and resources are essential for recovery.
Personal Stories: Real stories of recovery emphasize hope and resilience.
Interactive Q&A: Engage the audience and encourage discussion.
Conclusion: Recap key points and emphasize the importance of awareness, prevention, and seeking help.
Resources: Provide contact information and links for further support.
Letter to MREC - application to conduct studyAzreen Aj
Application to conduct study on research title 'Awareness and knowledge of oral cancer and precancer among dental outpatient in Klinik Pergigian Merlimau, Melaka'
R3 Stem Cell Therapy: A New Hope for Women with Ovarian FailureR3 Stem Cell
Discover the groundbreaking advancements in stem cell therapy by R3 Stem Cell, offering new hope for women with ovarian failure. This innovative treatment aims to restore ovarian function, improve fertility, and enhance overall well-being, revolutionizing reproductive health for women worldwide.
Comprehensive Rainy Season Advisory: Safety and Preparedness Tips.pdfDr Rachana Gujar
The "Comprehensive Rainy Season Advisory: Safety and Preparedness Tips" offers essential guidance for navigating rainy weather conditions. It covers strategies for staying safe during storms, flood prevention measures, and advice on preparing for inclement weather. This advisory aims to ensure individuals are equipped with the knowledge and resources to handle the challenges of the rainy season effectively, emphasizing safety, preparedness, and resilience.
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...rightmanforbloodline
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardson, Verified Chapters 1 - 18, Complete Newest Version
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardson, Verified Chapters 1 - 18, Complete Newest Version
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardson, Verified Chapters 1 - 18, Complete Newest Version
We are one of the top Massage Spa Ajman Our highly skilled, experienced, and certified massage therapists from different corners of the world are committed to serving you with a soothing and relaxing experience. Luxuriate yourself at our spas in Sharjah and Ajman, which are indeed enriched with an ambiance of relaxation and tranquility. We could confidently claim that we are one of the most affordable Spa Ajman and Sharjah as well, where you can book the massage session of your choice for just 99 AED at any time as we are open 24 hours a day, 7 days a week.
Visit : https://massagespaajman.com/
Call : 052 987 1315
Gemma Wean- Nutritional solution for Artemiasmuskaan0008
GEMMA Wean is a high end larval co-feeding and weaning diet aimed at Artemia optimisation and is fortified with a high level of proteins and phospholipids. GEMMA Wean provides the early weaned juveniles with dedicated fish nutrition and is an ideal follow on from GEMMA Micro or Artemia.
GEMMA Wean has an optimised nutritional balance and physical quality so that it flows more freely and spreads readily on the water surface. The balance of phospholipid classes to- gether with the production technology based on a low temperature extrusion process improve the physical aspect of the pellets while still retaining the high phospholipid content.
GEMMA Wean is available in 0.1mm, 0.2mm and 0.3mm. There is also a 0.5mm micro-pellet, GEMMA Wean Diamond, which covers the early nursery stage from post-weaning to pre-growing.
The best massage spa Ajman is Chandrima Spa Ajman, which was founded in 2023 and is exclusively for men 24 hours a day. As of right now, our parent firm has been providing massage services to over 50,000+ clients in Ajman for the past 10 years. It has about 8+ branches. This demonstrates that Chandrima Spa Ajman is among the most reasonably priced spas in Ajman and the ideal place to unwind and rejuvenate. We provide a wide range of Spa massage treatments, including Indian, Pakistani, Kerala, Malayali, and body-to-body massages. Numerous massage techniques are available, including deep tissue, Swedish, Thai, Russian, and hot stone massages. Our massage therapists produce genuinely unique treatments that generate a revitalized sense of inner serenely by fusing modern techniques, the cleanest natural substances, and traditional holistic therapists.
2. List of acronyms
CAM Catchment area meeting
CEE Core essential element
DQA Data quality assurance
DTG Dolutegravir
FSW Female sex worker
HRST High risk screening tool
KP Key population
MARP Most at risk population
OVC Orphans and vulnerable children
PIP Performance improvement plan
PPSS Pediatric psychosocial support
ASM Appointment spacing model
QI Quality improvement
SIMS Site improvement through monitoring system
ICT Index Case Testing
TPT TB preventive Therapy (INH prophylaxis)
MDT Multidisciplinary team
3. List of acronyms…
HF Health facility
EAS Enhanced adherence support
NACS Nutrition assessment, counseling and support
HEI HIV Exposed infant
DBS Dried blood spot
PLHIV People living with HIV
PMT Performance monitoring team
PrEP Pre-exposure prophylaxis
RHB Regional Health Bureau
STI Sexually transmitted infection
SNS Social network strategy
TAT Turn around time
TLD Combination of Tenofovir , Lamivudine & Dolutegravir
TLE Combination of Tenofovir, Lamivudine & Efavirenz
VL Viral load
ZHD/THD Zonal Health Department/Town Health Department
4. Previous CAM action points
No Action points from the last six
month
Actions taken Remarks
1 Low HIV testing performance Discusion on MDT
meeting .
Monitor it through
Internal mentorship
on progress
2 ICT register was not updated(elicited
contacts was not tested)
work with ACMs
Phone calling.
3 QI project was not designed. NOT done ART focal
and
providers
were not
trained
5. Major Transition Activities
S. N Activity #/Yes/No
1 # of HIV related QI project/s implemented in the last
quarter/six months
0
2 If yes, briefly discuss the QI project outcome/s
3 # of DQA conducted by zone at the facility in the last
quarter/ six months
0
4 Is SIMS visit conducted at your facility in the last quarter/six
months
NO
5 If yes, have you developed performance improvement plan
(PIP) /rescored? -----
6 Briefly discuss the challenges associated with infection prevention
and control (IPC) activities in the last quarter/six months including
the 4 IPC project sites (FHCSH, GUH, WCSH & DCSH)
6. Major Transition Activities…
No Activity six
months
plan
Perfo
rman
ce
%/#
9 # of external mentorship conducted in the
last quarter/ six months (For mentoring HFs
only)
23 10 Mentoring was
not conducted
in the 1st Quar
10 # of report submitted to cluster
hospital/ZHD/RHB in the last quarter/six
months (For mentoring HF only)
1 1
11 # of internal mentorship conducted in the
last quarter/six months
3 3
12 # of MDT meeting conducted and minute
archived in the last quarter/six months
3 3
13 # of PMT meeting conducted and minute
archived in the last quarter/six months
3 3
14 # of supervision received from Woreda
health offices or ZHD/THD /RHB
(Specify)
2 3 100%
8. HIV prevention…
No. Activities Quarter/
6
months
plan
Performance in #
(%) in 3/6 months
1
# of condoms distributed for MARPs 0 0
2
# of condoms distributed for the general
population
2514 1850
3
#of PLHIV addressed with positive living
education
1665 984
4
# of FSW reached with HIV test and other
package of services at KP friendly clinic (For
KP friendly sites only)
0 0
5
# of high risk FSW reached with HIV test and
other package of services through SNS (For
SNS sites only)
0 0
9. HIV prevention…
No. Activities Quarter/s
ix months
plan
Performance
in # (%) in
3/6 months
6
# of PLHIV received at least 1 type of care and
support from 3C’s*
0 0
7
# of OVCs received at least 1 type care and support
from 3C’s
0 0
8
# of clients put on PrEP 05 02
9
# of clients lost from PrEP 0 0
10
# of clients currently on PrEP 05 02
11. Status of HIV risk screening tool (HRST) utilization at HFRisk
Screening Tool (HRST)
No. Activities Quarter
/six
months
plan
Performanc
e in # (%)
in the
3/6
months/Y/N
1 Is there HRST available ? YES
2 If yes,
2.1
# patients visited HFs in the last quarter/six months 22455 25959
2.2 # Patients screened in the last quarter/six months 22455 8211
2.3 # Eligible for HIV testing in the last quarter/six months 2100 1780
2.4
# Tested for HIV in the last quarter/six months 2100
1009 kit
shortage
12. HIV testing services
No. Activities Quarte
r/six
months
plan
Achive
ment
Performa
nce in #
(%) in
3/6
months
1 Total # of individuals tested for HIV in the
last quarter/six months
1.1 adult
1.2 children
2570 1570 61.1%
2226 1501 67.4%
344 69 20.%
2 Total # of HIV positive clients identified
2.1 adults
2.2 children
30 18 60%
25 17 68%
5 1 20%
3
# of HIV +ve clients received from other
facility/community based organizations
(CBOs)
03 01 33.3%
4
# of HIV +ve clients linked at HIV
positive tracking register
43 19
13. Index case testing status at ART and PMTCT clinic
No. Activities Quarter/si
x months
plan
Performanc
e in # ( %) in
3/6 months
1 # of clients newly started ART in the last quarter/six
months
30 16
2 # of spouse/non-spouse ,children and parent of
newly started ART clients registered at index case
register
30 16
3
# of spouse/non-spouse ,children and parent of
newly started ART clients registered at index case
register with unknown status
10 9
4
# of spouse/non-spouse ,children and parent of
newly started ART clients tested for HIV
4.1 # tested positive
4.2 # linked and started ART
10 7
05 02
05 02
14. Index case testing for high viral load (VL) clients
No. Activities Quarter/
6 ms plan
Performance
in # (%) in
3/6 ms
1 # of PLHIV on ART with high VL results in
the last quarter/six months
0 0
2
# of spouse/non-spouse and children of high
VL clients registered at index case register
0 0
3
# of spouse/non-spouse and children of
PLHIV with high VL tested for HIV
3.1 # tested positive
3.2 # linked and started ART
0 0
0 0
0 0
0 0
0 0
15. HIV Exposed Infants HIV testing
No
.
Activities Quarte
r/6
months
plan
Performance
in # (%) in
3/6 months
1
# of HEIs identified in the last quarter/six months
13
2 # of HEIs who received ARV prophylaxis 13
3 # of DBS samples sent to testing site in the last
quarter/six months
8
4
# of HEIs tested HIV positive with DNA PCR in
the last quarter/six months
0
5
# of HEIs tested positive, tracked and started within
with in 7 days
0
6 Average DBS TAT in the last quarter/six months
3hr
16. CBS implementation
No. Activities Quarter/6
months
plan
Performance in #
(%) in
3/6 months
1
Total # of newly identified HIV positive
individuals with completed CRF (Case
Reporting Format)
30 18
2
Total # of HIV positive clients tested for
recency testing
25 12
3
Total # of individuals with recent infection
01
17. Sexual transmitted infection (STI) and HIV testing
No. Activities Quarte
r/six
months
plan
Performance
in # (%)
1 # of STI cases diagnosed in the facility in the last
quarter/six months
45 43
2
# of clients treated with syndromic approach in the last
quarter/six months
45 43
3
# of partners of STI cases notified , diagnosed and
managed for STI in the last quarter/six months
35 29
4
# STI clients tested for HIV in the last quarter/six
months
45 43
5
# STI clients tested HIV positive in the last
quarter/six months
03 01
6
# of clients tested HIV +ve linked to ART clinic in the
last quarter/six months
03 01
18. Post GBV/sexual violence (SV) service
No. Activities Quarter /6
months
plan
Performanc
e in # (%)
in 3/6
months
1 # of GBV/SV survivors who visited facility in the
quarter
5 27
2
# of GBV/SV Survivors who got Post GBV/SV
clinical care
5 27
3
# GBV/SV survivors provided with PEP 5 0
20. ART initiation performance
Activities Quarter/six
months plan
Performance in
# ( %) in
3/six months
1
# of clients linked to care (# of clients registered
on HIV positive tracking register)
30 19
2
# of clients initiated ART with in a week including
same (rapid initiation) day in last quarter/6
months
2.1 adults
2.2 children
30 16
25 16
05 0
3 # of clients initiated ART after a week
3.1 adults
3.2 children
0 0
0 0
4 # of clients referred to other HFs
0
03
5 # client with confirmed referral 0 03
21. Not yet started clients status
Activities Quarter/six
months plan
Performance in #
(%) in the
3/6 months/Y/N
1 # of total clients not yet started ART 0
2 Reasons for not yet started clients
3 Does the facility monitor and follow not yet
started clients with not yet started checklist
yes
22. ASM and NACS performance
No Activities Quarter/6m
months plan
Performance
in # (%) in 3/6
months
1
Currently on ART
4.1 adult
4.2 Children
1057
1028
29
2 # of stable ART clients 967
3 # of stable clients ever enrolled in to appointment spacing
model (ASM)
606
4
# of stable clients ever enrolled in to Fast Track ART Refill
(FTAR)
96
5 # of stable clients refused to be enrolled in to differentiated
service delivery model (DSD)
207
6 Total # of PLHIV assessed and diagnosed as undernourished 34
7
Total # of PLHIV who received therapeutic/supplementary 0
23. ART optimization
No. Activities Quarter/s
ix months
plan
Performance in
# (%) in
3/6 months
(Y/N)
1
Does the facility have any clients who are on NVP
based regimen (if yes specify the reason )?
NO
2
# of existing pediatric clients aged < 10yrs & >
20kg ) shifted to ABC/3TC/DTG
0
3
# of existing pediatrics clients aged< 10yrs & <20kg
shifted to ABC/3TC/LPV/r
0
4
# of existing pediatrics clients aged > 10yrs &
>30kg shifted to TLD/TLE
3
24. ART client retention
No. Activities Quarter/six
months plan
Performance
in # (%) in
3/6 months
1 TI in the last quarter/six months 4
2
TO in the last quarter/six months
8
3
Lost to follow up/Drop/ in the last quarter/six
months
5
4
# of clients traced back in the last
quarter/6months
4
5 # of total deaths in the last quarter/ six months
6
6
# of deaths for which death audit is done in the
last quarter/six month?
6
7
Net treatment current increment (treatment
current in last quarter/6 months - treatment
current in the previous quarter/6 months)
-6
25. TB/HIV collaboration
No
.
Activities Quarter 6
months
plan
Performance in #(%)
in 3/6 months
1
# of patients diagnosed for TB in the last
quarter/6 months
8 10
2
# of patients diagnosed for TB and tested for
HIV in the last quarter/6 months
8 10
3
# of patients diagnosed TB and tested HIV
positive for HIV in the last quarter/6 months
tested HIV positive
3 0
4
# of TB patients diagnosed in the last quarter/6
months tested HIV positive and started CPT
3 0
5
# of TB patients diagnosed in the last quarter/6
months tested HIV positive and started ART
3 0
26. TB/HIV collaboration…
No. Activities Quarter/
6 ms plan
Performance in
# (%) in 3/6
months
6
Proportion of ever started TPT (TPT started/TX-
CURR)
100% 98%
7
Proportion of clients completed
TPT(completed TPT/started TPT)
95% 92%
8
Existing ART clients who were screened for TB at
the end of the quarter/six months
1057 1057
9
Screen negative existing clients who started TPT
in the quarter
0 18
10
Proportion of newly enrolled in HIV care who
started TPT during the last quarter/six months
30 11
27. Pediatric psychosocial support (PPSS)
No
.
Activities Quarter/
six
months
plan
Performanc
e in # (%)
in 3/6
months
1 # of children on ART disclosed their HIV status
in the last quarter/six months
05 2
2 # of children disclosed their HIV status and
enrolled to the PPSS in the last quarter/six
months
05 2
3 # of children currently participating in the PPSS
program
53 57
28. Cervical cancer screening and management
N
o.
Activities Quarter
/ six
months
plan
Performance
in # (%) in
3/6 months
1
# WLHIV aged 15-49 screened for cervical cancer
with VIA for first time in the reporting period
335 21 (only on
october)
2 # found positive with VIA for dysplasia
0
3 # of clients treated with cryotherapy
0
4
# of clients who received follow up after treatment in
the reporting period
0
29. Mental health integration (MHI)
No
.
Activities Quarter/
six
months
plan
Performance
in # (%) in 3/6
months
1 # of eligible clients screened for mental health
problem
1063 1057
2
# of clients who have symptoms of MH illness
0 02
3 # of clients referred to clinician for mental health
evaluation
0 02
31. Viral load test performance
No. Activities Quarter
/six
months
plan
Performanc
e in # (%)
in 3
/ 6 months
1 Total viral load specimen sent in the last quarter/six
months
520 305
2
Total viral load result received in the last quarter/six
months
149
67-Reject
3
# of viral load results > 1000 copies/ml in the
quarter quarter/6 months
0
4
Average VL turnaround time (TAT) in the quarter/6
months
29 days
32. Viral load test performance …
No. Activities Quarter
/six
months
plan
Performanc
e in # (%)
in 3/6
months
5 # of high VL clients enrolled in EAS in the last
quarter/six months
0 0
6
# of high VL clients completed EAS in the last
quarter/six months
0 02
7
# of high VL clients completed EAS and 2nd VL test
done in the last quarter/six months
02
8
# of clients with 2nd VL viral load results > 1000
copies/ml in the last quarter/6 months
0
9
# of clients switched to the second/3rd line ART in
the last quarter/six months
0
33. Rapid test kit supply
S.|
N
Activity Stat
pack
Abon SD
Bio
line
1 Total # of rapid HIV test kits at the
beginning of the last quarter/6 months
0 1 box 0
2 Total # of rapid HIV test kits received last
quarter/6 months
96box 1box 2box
3 Total # of rapid HIV test kits expired /
damaged last quarter/6 months
3box 0 0
4 Total # of rapid HIV test kits utilized last
quarter/6 months
80box 2box 1box
5 Total # of rapid HIV test kit currently stock
on hand last quarter/6 months
13box 0 1box
6 Total tests reactive /positive in the last
quarter/6 months
60 34 34
34. Pediatrics ARV drug stock status
Activity
ABC
+
3TC
(120+60)
AZT
+3TC
(60+30)
Lop/r
pellet
Lop/r
125mg
1 Total # of packs at the
beginning of the last
quarter/6 months
70 20 0 100
2 Total # of packs received
last quarter/6 months
200 16 50 0
3 Total # of packs expired /
damaged last quarter/6
months
0 0 0 0
4 Total # of packs utilized last
quarter/6 months
270 0 50 68
5 Total # of packs currently
stock on hand last quarter/6
months
0 36 0 32
35. ARV drugs & rapid test kit supply…
S.
N
Activity Yes (List) No If yes, for
how long?
1 Was there rapid test kit interruptions in last
quarter/6 months?
. 2 month
2 Was there DBS kit interruption in the last
quarter/6months?
. 3month
3 Was there Pediatrics 1st,2nd & 3rd ARV drugs
interruptions in last quarter/6 months?
DTG
50mg.
1month
4 Was there Adult 1st,2nd & 3rd line ARV drugs
interruptions in last quarter/6 months?
.
5 Was there INH/ CPT interruption in the last
quarter/6 months?
.
6 Was there interruption of VL test tube in the
last quarter/six months?
Yes
ppt/EDTA
test tube
3month
36. Challenges
No Challenges Actions undertaken
1 Stock out of Nutirtional supplement Counseling on nutrrition
2 Stock out of ABC/3TC, RTKs and
EDTA/PPT tubes
communicate with EPSA
3 Stockout of CD4 cartilage communicate with EPSA